Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP290864.RABXVvp-gbNRasx4ULun7QtHBBo7rbWS3XDwGA9Xe_hxQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP290864.RABXVvp-gbNRasx4ULun7QtHBBo7rbWS3XDwGA9Xe_hxQ130_assertion type Assertion NP290864.RABXVvp-gbNRasx4ULun7QtHBBo7rbWS3XDwGA9Xe_hxQ130_head.
- NP290864.RABXVvp-gbNRasx4ULun7QtHBBo7rbWS3XDwGA9Xe_hxQ130_assertion description "[The depletion of B cells by anti-CD20/19 monoclonal antibody Retuximab� used in autoimmune diseases therapy leads to systemic side effects and should be significantly improved.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290864.RABXVvp-gbNRasx4ULun7QtHBBo7rbWS3XDwGA9Xe_hxQ130_provenance.
- NP290864.RABXVvp-gbNRasx4ULun7QtHBBo7rbWS3XDwGA9Xe_hxQ130_assertion evidence source_evidence_literature NP290864.RABXVvp-gbNRasx4ULun7QtHBBo7rbWS3XDwGA9Xe_hxQ130_provenance.
- NP290864.RABXVvp-gbNRasx4ULun7QtHBBo7rbWS3XDwGA9Xe_hxQ130_assertion SIO_000772 21677771 NP290864.RABXVvp-gbNRasx4ULun7QtHBBo7rbWS3XDwGA9Xe_hxQ130_provenance.
- NP290864.RABXVvp-gbNRasx4ULun7QtHBBo7rbWS3XDwGA9Xe_hxQ130_assertion wasDerivedFrom befree-20150227 NP290864.RABXVvp-gbNRasx4ULun7QtHBBo7rbWS3XDwGA9Xe_hxQ130_provenance.
- NP290864.RABXVvp-gbNRasx4ULun7QtHBBo7rbWS3XDwGA9Xe_hxQ130_assertion wasGeneratedBy ECO_0000203 NP290864.RABXVvp-gbNRasx4ULun7QtHBBo7rbWS3XDwGA9Xe_hxQ130_provenance.